Close Menu

NEW YORK – MiLaboratories and MIODx today announced an agreement to collaborate on products and services related to immune repertoire profiling.

Under the terms of the agreement, the companies will offer contract research services to the US and European markets in "all applications related to sequencing-based probing of human and animal adaptive immune systems," the firms said in a statement.

MIODx will carry out wet lab services in its San Jose, California facilities.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

Mar
30
Sponsored by
GenomeWeb/ABRF

This webinar features two speakers who will discuss novel computational approaches to optimize sequencing workflows on Oxford Nanopore sequencing platforms.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.